Evidence-based medicine works best when there is evidence: Challenges in palliative medicine when randomized controlled trials are not possible

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 23, Issue 1, 2009, Pages 48-50

  Kongsgaard, Ulf E ^a,b   Werner, Mads U ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Rigshospitalet   (Denmark)

Author keywords

Pain; Palliative care; Randomized Controlled trial; Study design

Indexed keywords

CENTRAL DEPRESSANT AGENT; OPIATE; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT; NARCOTIC ANALGESIC AGENT;

ADVANCED CANCER; CANCER PAIN; DELIRIUM; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; LIFE EXPECTANCY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; METHODOLOGY; NERVE BLOCK; NOTE; PAIN; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PATIENT PARTICIPATION; POLYPHARMACY; RANDOMIZED CONTROLLED TRIAL; SEDATION; TERMINAL DISEASE; ARTICLE; HOSPICE;

ANALGESICS, OPIOID; EVIDENCE-BASED MEDICINE; HOSPICES; HUMANS; HYPNOTICS AND SEDATIVES; PAIN; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 67649510430     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280902728237     Document Type: Note

References (15)

1. Hardy C. Placebo-controlled trials in palliative care; the argument for. Palliat Med. 1997;11:415-418.
2. Kirkhham S, Abel J. Placebo-controlled trials in palliative care: the argument against: Palliat Med. 1997;11:489-492.
3. Clark PI, Leaverton PE. Scientific and ethical issues in the use of placebo controls in clinical trials. Ann Rev Public Health. 1994;15:290-1238
4. Wee B, Hadley G, Derry S. How useful are systematic reviews for informing palliative care practice? Survey of 25 Cochrane systematic reviews. BMC Palliat Care. 2008;7:13.
5. Kaasa S, De CF. Palliative care research. Eur J Cancer. 2001;37(Suppl 8):S153-S159.
6. Kongsgaard UE,Werner MU. Clinical trials: cancer pain. In: Breivik H, CampbellW, Nicholas MK, eds. Clinical Pain Management: Practice and Procedures, 2nd ed. London: Hodder Arnold; 2008:538-551.
7. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a metaanalysis. Anesth Analg. 1995;80:290-295.
8. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassilethi BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care. 1990;6:7-11.
9. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med. 1997;11:140-144.
10. Fainsinger RL, Waller A, Bercovici M, Bengtson K, Landman W, Hosking M, Nunez-Olarte JM, deMoissac D. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med. 2000;14:257-265.
11. Sykes N, Thorns A. Sedative use in the last week of life and the implications for en-of-life decision making. Arch Intern Med. 2003;163:341-344.
12. White CD,Hardy JR, GilshenanKS, CharlesMA, Pinkerton CR. Randomised controlled trials of palliative care-a survey of the views of advanced cancer patients and their relatives. Eur J Cancer. 2008;44:1820-1828.
13. JacksonK,Ashby M, Martin P, Pisasale M, Brumley D, Hayes B. "Burst" ketamine for refractory cancer pain; an open label audit of 39 patients. J Pain Symptom Manage. 2001;22:834-842.
14. JacksonK,Ashby M, Doodchild C. Subanesthetic ketamine for cancer pain: by insisting on level I/II evidence, do we risk throwing the baby out with the bath water? J Pain Symptom Manage. 2005;29:328-330.
15. Flemming K, Adamson J, Atkin K. Improving the effectiveness of interventions in palliative care: the potential role of qualitative research in enhancing evidence from randomized controlled trials. Palliat Med. 2008;22:123-131.